ILKAY vs. TMO
ILKAY (Iluka Resources Ltd ADR) and TMO (Thermo Fisher Scientific Inc.) are both stocks. ILKAY operates in Other Industrial Metals & Mining (Basic Materials), while TMO operates in Diagnostics & Research (Healthcare). Over the past 10 years, ILKAY returned 6.16%/yr vs 14.21%/yr for TMO. Their 0.02 correlation means their historical movements had little consistent relationship.
Performance
ILKAY vs. TMO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ILKAY achieves a 6.96% return, which is significantly higher than TMO's -0.69% return. Over the past 10 years, ILKAY has underperformed TMO with an annualized return of 6.16%, while TMO has yielded a comparatively higher 14.21% annualized return.
ILKAY
- 1D
- -11.21%
- 1M
- -13.91%
- 6M
- 6.26%
- YTD
- 6.96%
- 1Y
- 24.81%
- 3Y*
- -16.35%
- 5Y*
- -6.72%
- 10Y*
- 6.16%
- ALL TIME*
- 1.20%
TMO
- 1D
- -0.43%
- 1M
- 9.72%
- 6M
- -0.55%
- YTD
- -0.69%
- 1Y
- 24.48%
- 3Y*
- 2.03%
- 5Y*
- 1.52%
- 10Y*
- 14.21%
- ALL TIME*
- 12.29%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $66.96K | $47.62K | $61.22K | |
| $1.57B | $1.22B | $1.19B |
ILKAY vs. TMO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ILKAY Iluka Resources Ltd ADR | 6.96% | 19.25% | -26.93% | -30.67% | -8.72% | 83.16% | 24.66% | 6.24% | -17.73% | 44.05% |
TMO Thermo Fisher Scientific Inc. | -0.69% | 11.78% | -1.72% | -3.36% | -17.29% | 43.54% | 43.72% | 45.55% | 18.21% | 35.03% |
Correlation
The correlation between ILKAY and TMO is -0.03, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | -0.03 |
Correlation (3Y) Balances recent behavior with more history. | -0.00 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.01 |
Correlation (10Y) Provides a long-term view across more market conditions. | -0.00 |
Correlation (All Time) Calculated using the full available price history since Feb 4, 2011 | 0.02 |
Fundamentals
ILKAY:
$1.71B
TMO:
$213.42B
ILKAY:
-A$1.12
TMO:
$18.62
ILKAY:
1.28
TMO:
4.64
ILKAY:
1.17
TMO:
4.04
ILKAY:
A$1.89B
TMO:
$46.34B
ILKAY:
A$789.87M
TMO:
$18.71B
ILKAY:
A$565.16M
TMO:
$10.94B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ILKAY vs. TMO — Risk / Return Rank
ILKAY
TMO
ILKAY vs. TMO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Iluka Resources Ltd ADR (ILKAY) and Thermo Fisher Scientific Inc. (TMO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ILKAY | TMO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.53 | ||
| Sortino ratioReturn per unit of downside risk | -0.46 | ||
| Omega ratioGain probability vs. loss probability | 1.12 | 1.16 | -0.04 |
| Calmar ratioReturn relative to maximum drawdown | 0.41 | 0.74 | -0.33 |
| Martin ratioReturn relative to average drawdown | 0.72 | 1.46 | -0.74 |
Loading charts...
Drawdowns
ILKAY vs. TMO - Drawdown Comparison
The maximum ILKAY drawdown since its inception was -79.51%, which is greater than TMO's maximum drawdown of -71.16%. Use the drawdown chart below to compare losses from any high point for ILKAY and TMO.
Loading charts...
Drawdown Indicators
| ILKAY | TMO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -79.51% | -71.16% | -8.35% |
Max Drawdown (1Y)Largest decline over 1 year | -43.96% | -31.38% | -12.58% |
Max Drawdown (3Y)Largest decline over 3 years | -72.03% | -37.28% | -34.75% |
Max Drawdown (5Y)Largest decline over 5 years | -77.94% | -40.95% | -36.99% |
Max Drawdown (10Y)Largest decline over 10 years | -77.94% | -40.95% | -36.99% |
Current DrawdownCurrent decline from peak | -51.52% | -12.79% | -38.73% |
Average DrawdownAverage peak-to-trough decline | -47.21% | -18.12% | -29.09% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 25.06% | 15.94% | +9.12% |
Volatility
ILKAY vs. TMO - Volatility Comparison
Iluka Resources Ltd ADR (ILKAY) has a higher volatility of 29.36% compared to Thermo Fisher Scientific Inc. (TMO) at 10.24%. This indicates that ILKAY's price experiences larger fluctuations and is considered to be riskier than TMO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ILKAY | TMO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 29.36% | 10.24% | +19.12% |
Volatility (6M)Calculated over the trailing 6-month period | 51.59% | 24.17% | +27.42% |
Volatility (1Y)Calculated over the trailing 1-year period | 77.71% | 30.65% | +47.06% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 56.80% | 27.64% | +29.16% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 52.03% | 26.57% | +25.46% |
Dividends
ILKAY vs. TMO - Dividend Comparison
ILKAY's dividend yield for the trailing twelve months is around 0.86%, more than TMO's 0.31% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ILKAY Iluka Resources Ltd ADR | 0.86% | 1.03% | 1.68% | 3.58% | 7.39% | 1.33% | 73.30% | 2.45% | 4.10% | 0.55% | 9.11% | 2.95% |
TMO Thermo Fisher Scientific Inc. | 0.31% | 0.30% | 0.30% | 0.26% | 0.22% | 0.16% | 0.19% | 0.23% | 0.30% | 0.32% | 0.43% | 0.42% |
Financials
ILKAY vs. TMO - Financials Comparison
This section allows you to compare key financial metrics between Iluka Resources Ltd ADR and Thermo Fisher Scientific Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ILKAY vs. TMO - Profitability Comparison
ILKAY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Iluka Resources Ltd ADR reported a gross profit of -124.38M and revenue of 429.57M. Therefore, the gross margin over that period was -29.0%.
TMO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Thermo Fisher Scientific Inc. reported a gross profit of 4.94B and revenue of 11.99B. Therefore, the gross margin over that period was 41.2%.
ILKAY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Iluka Resources Ltd ADR reported an operating income of -205.17M and revenue of 429.57M, resulting in an operating margin of -47.8%.
TMO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Thermo Fisher Scientific Inc. reported an operating income of 2.09B and revenue of 11.99B, resulting in an operating margin of 17.4%.
ILKAY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Iluka Resources Ltd ADR reported a net income of -373.42M and revenue of 429.57M, resulting in a net margin of -86.9%.
TMO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Thermo Fisher Scientific Inc. reported a net income of 1.74B and revenue of 11.99B, resulting in a net margin of 14.5%.
Frequently Asked Questions
ILKAY and TMO have a correlation of -0.03, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ILKAY has higher volatility (29.36%) compared to TMO (10.24%). In terms of maximum drawdown, ILKAY dropped -79.51% vs TMO's -71.16%.
TMO currently has the higher Sharpe Ratio (0.76 vs 0.23), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ILKAY and TMO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer